During American Pharmacists Month, Steve Anderson, president and CEO of the National Association of Chain Drug Stores, said that appreciation for pharmacists should be intensified due to their services during the public health crisis.
Biosimilars could reach $80 billion in aggregate sales over the next five years, including $16 billion to $36 billion in 2024, according to the IQVIA Institute for Human Data Science's study.
Robert Mauch, AmerisourceBergen executive vice president and group president, assumes Healthcare Distribution Alliance board leadership from Greg Drew, who will remain a member of the executive committee.
Less well-known are the retailers that have carved out a niche in specialty pharmacy and are sprinting forward and experiencing less pain than their retail brethren that have not yet stepped into this rapidly growing and profitable arena.
Omnicell's acquisition of PSG's 340B Link business will help various healthcare entities manage compliance and capture 340B drug cost savings on outpatient prescriptions.
